The Aesthetic Guide

3 The Aesthetic Guide | November/December 2020 | www.theaestheticguide.com The treatments are usually delivered twice a week, with each treatment typically lasting for 30 minutes. During the treatment, the provider is present to monitor the patient and adjust treatment settings if necessary. The procedure is not associated with any downtime. Thus, patients can return to their daily activities immediately post-treatment. After completing the entire procedure, patients attend a follow-up visit about two to three months after the last treatment to discuss their outcomes and satisfaction. Results Patient Composition Facial Plastic Surgery Practice During the analyzed 18 months, a total of 166 patients underwent the HIFEM procedure in the facial plastic surgery practice. Out of all the patients treated by HIFEM, 77% were females and 23% were male. However, this proportion of male subjects increased to 39.29% over the last three months. The average age of the patients was 48.0±8.1 (males 51.9±8.3, females 46.8±8) The age group 50-59 was dominant among both the female (41.07%) and male (63.68%) population, followed by the 40-49 age group as 37.62% of females and 27.37% of males fell into this group. See Figure 1 for detailed age composition. Regarding ethnicity, a majority of the patients were Caucasian (85%) followed by African American (5%), Hispanic (5%) and Asian (5%). Out of all patients, 76% were existing patients to the practice who have already undergone another procedure in the past. However, 24% of patients who came to practice for the first time were attracted by the Emsculpt procedure itself. Although the primary focus of the practice is on facial rejuvenation, body contouring procedures are also offered to the patients. As such, Emsculpt is primarily used as a standalone treatment; however, it is also used in conjunction with cryolipolysis in several patients. Medical Spa In the aesthetic clinic, a total of 285 patients received the full HIFEM treatment cycle with the Emsculpt device during the examined 18 months. The majority of the patients were females, representing 85.4% of all patients, while males comprised 14.6% of the entire patient group. The average age of all treated subjects was 42.4±8.6 (females 41.7±8.4, males 46.1±9.3). As shown in Figure 2, most of the patients (79%) were in the mid-age range 30-49, as 41% of the patients fall into the group 40-49, and 38% of patients between 30 and 39 years of age. Among females, the age-layout was similar to that of the entire patient population, as 41% of patients were from the age group 40-49, 40% were of age between 30 and 39 and 9% were females from age range 50-59. Only 4% and 5% of female patients were younger than 30 and older than 60 years, respectively. Among males, on the other hand, the most frequent age groups were 40-48 (38%) and 30-39 (37%), followed by the age group 30-39 (25%). Altogether, only 1% of males were younger than 30 or older than 60 years. 6.39% 10.27% 35.27% 46.26% 1.81% Age distribution <30 30-39 40-49 50-59 60+ 4.42% 37.59% 41.11% 13.27% 3.60% Age distribution <30 30-39 40-49 50-59 60+ Figure 2 Figure 1